Proadrenomedullin (pro-ADM) for the diagnosis of proven and clinical sepsis in a newborn cohort including preterm newborns has not been investigated. We aimed to investigate the value of pro-ADM as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback